Abstract
Aim:
The aim of the present study was to investigate whether low dose genistein affects the invasion and epithelial mesenchymal transition (EMT) of prostate cancer (PCa) cells.
Methods:
Human PCa cell lines, IA8-ARCaP and LNCaP/HIF-1a, were used in this study. The cell lines were found to process EMT in our previous study. The PCa cells were treated with increasing concentrations, from 0.1 to 75μmol/L. Proliferation was assessed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. EMT was proven by cell morphological transition and the expression changes of EMT-related markers, which were confirmed by RT-PCR, Western blotting, and indirect immunofluorescence labeling. Transwell invasion assay was used to analyze the invasive potency.
Results:
The addition of genistein to the medium reduced the IA8-ARCaP and LNCaP/HIF-1a viable cell number in a dose-dependent manner (with increasing concentrations from 15 to 75 μmol/L). Less than 15 μmol/L genistein was selected as the low dose concentration, which did not affect cell proliferation. The treatment of cells with low-dose genistein induced the reversal of EMT, which was confirmed by cell morphological transition and the expression changes of EMT-related markers. The reversal of EMT in the PCa cells by low-dose genistein was in a dose-dependent manner. Moreover, low-dose genistein effectively inhibited invasion of the PCa cells in vitro.
Conclusion:
These results showed that treatment with low-dose genistein may be a potential strategy for the suppression of invasive growth through the reversal of EMT in cancer cells, which justifies the potential use of soybean foods as a practical chemopreventive approach for patients with PCa.
Similar content being viewed by others
Article PDF
References
Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005; 97: 1407–7.
Bracarda S, de Cobelli O, Greco C, Prayer-Galetti T, Valdagni R, Gatta G, et al. Cancer of the prostate. Crit Rev Oncol Hematol 2005; 56: 379–96.
Thiery JP . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442–54.
Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, et al. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 2006; 66: 1664–73.
Whitbread AK, Veveris-Lowe TL, Lawrence MG, Nicol DL, Clements JA . The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition. Biol Chem 2006; 387: 707–14.
Kasper S, Cookson MS . Mechanisms leading to the development of hormone-resistant prostate cancer. Urol Clin North Am 2006; 33: 201–10.
Messina MJ, Persky V, Setchell KD, Barnes S . Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21: 113–31.
Parnes HL, Figg WD . Chemoprevention in prostate cancer. Pharma-cotherapy 2006; 26: 1533.
Clinical development plan: genistein. J Cell Biochem Suppl 1996; 26: 114–26.
Severson RK, Nomura AM, Grove JS, Stemmermann GN . A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989; 49: 1857–60.
Schleicher RL, Lamartiniere CA, Zheng M, Zhang M . The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory sex gland carcinoma. Cancer Lett 1999; 136: 195–201.
Valachovicova T, Slivova V, Bergman H, Shuherk J, Sliva D . Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1 -dependent and -independent pathways. Int J Oncol 2004; 25: 1389–95.
Iishi H, Tatsuta M, Baba M, Yano H, Sakai N, Akedo H . Genistein attenuates peritoneal metastasis of azoxymethane-induced intestinal adenocarcinomas in Wistar rats. Int J Cancer 2000; 86: 416–20.
Davis JN, Singh B, Bhuiyan M, Sarkar FH . Genistein-induced up-regulation of p21WAFl, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 1998; 32: 123–31.
Kyle E, Neckers L, Takimoto C, Curt G, Bergan R . Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 1997; 51: 193–200.
Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK . Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 1999; 129: 1628–35.
Santibanez JF, Navarro A, Martinez J . Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res 1997; 17: 1199–204.
Davis JN, Muqim N, Bhuiyan M, Kucuk O, Pienta KJ, Sarkar FH . Inhibition of prostate specific antigen expression by genistein in prostate cancer cells. Int J Oncol 2000; 16: 1091–7.
Crowell JA, Holmes CJ . Agent identification and preclinical testing. Cancer Treat Res 2001; 106: 1–30.
Luo Y, He DL, Ning L, Shen SL, Li L, Li X . Hypoxia-inducible factor-1 alpha induces the epithelial-mesenchymal transition of human prostatecancer cells. Chin Med J (Engl) 2006; 119: 713–8.
Luo Y, He DL, Ning L, Shen SL, Li L, Li X, et al. Over-expression of hypoxia-inducible factor-lalpha increases the invasive potency of LNCaP cells in vitro. BJU Int 2006; 98: 1315–9.
Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, et al. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 1996; 93: 15152–7.
Jiang YG, Luo Y, He DL, Li X, Zhang LL, Peng T, et al. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-lalpha. Int J Urol 2007; 14: 1034–9.
Romijn JC, Verkoelen CF, Schroeder FH . Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. Prostate 1988; 12: 99–110.
Hempstock J, Kavanagh JP, George NJ . Growth inhibition of prostate cell lines in vitro by phyto-oestrogens. Br J Urol 1998; 82: 560–3.
Bhatia N, Agarwal R . Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells. Prostate 2001; 46: 98–107.
Peterson G, Barnes S . Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 1993; 22: 335–45.
Onozawa M, Fukuda K, Ohtani M, Akaza H, Sugimura T, Waka-bayashi K . Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn J Clin Oncol 1998; 28: 360–3.
Geller J, Sionit L, Partido C, Li L, Tan X, Youngkin T, et al. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 1998; 34: 75–9.
Adlercreutz H, Markkanen H, Watanabe S . Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342: 1209–10.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported in part by grants from the National Natural Science Foundation of China (No 30500502) and the National 863 project of China (No 2006AA020705).
Rights and permissions
About this article
Cite this article
Zhang, Ll., Li, L., Wu, Dp. et al. A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells. Acta Pharmacol Sin 29, 1060–1068 (2008). https://doi.org/10.1111/j.1745-7254.2008.00831.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00831.x
Keywords
This article is cited by
-
Rottlerin and genistein inhibit neuroblastoma cell proliferation and invasion through EF2K suppression and related protein pathways
Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
-
Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway
BMC Cancer (2017)
-
Targeting Phenotypic Plasticity in Prostate Cancer
Current Molecular Biology Reports (2017)
-
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
Cancer and Metastasis Reviews (2014)
-
Synergistic effect of the novel benzochalcone derivative DK-78 and doxorubicin on MCF7-VN breast cancer stem cells
Journal of the Korean Society for Applied Biological Chemistry (2013)